Chronic Doctors Logo


Medical cannabis research published online in 2016 in the Journal of Obstetrics and gynaecology sough to determine the prevalence, tolerability, and self-reported effectiveness of cannabis in women with endometriosis.

Australian law currently requires legal medicinal cannabis use to follow specific, regulated pathways that limit prescription by this method; however, self-reported illicit use of cannabis remains relatively common in Australian women with endometriosis. ”* 

Although medical cannabis therapies, derived from the marijuana plant cannabis indica and cannabis sativa and prescribed by doctors in australia are considered by the TGA (Therapeutic Goods Australia) as ‘prescription medicines’ in all cities Sydney, Brisbane, Melboure, and states Queensland, NSW and Victoria, Australian medical cannabis therapies still need further rigorous research to confirm these more recent studies evident in the article stating

Women report good efficacy of cannabis in reducing pain and other symptoms, with few adverse effects reported. Further clinical research is warranted to determine the effectiveness of cannabis in managing endometriosis symptoms. In locations where medicinal cannabis is more accessible, there remains a paucity of evidence for its clinical efficacy with endometriosis-associated symptoms. ”*

These types of studies can assist doctors in making informed decisions in prescribing medical cannnabis to patients in Australia.

Look out for more article updates by the Chronic Doctors.
As with all posts for more information see the link to article and TGA guidelines below:

         Medicinal cannabis | Therapeutic Goods Administration (TGA)
Sinclair, Justin, et al. “Cannabis use, a self-management strategy among Australian women with endometriosis: results from a national online survey.” Journal of Obstetrics and Gynaecology Canada 42.3 (2020): 256-261.